FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data ...
Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable ...
For women who have stopped menstruating due to anorexia and/or excessive exercise — a condition known as functional hypothalamic amenorrhea (FHA) — the use of transdermal hormone replacement therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results